Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to study the effect of Human Papillomavirus (HPV) vaccination on
the elevation of antibody titer to 4 serotypes of HPV in patients with systemic lupus
erythematous and compare the antibody response with an equal number of age-matched healthy
women.